Oral Anticholinergic Medications (e.g., Glycopyrrolate, Oxybutynin) Cost in Korea

Mijan Mijan • July 29, 2025

Oral Anticholinergic Medications (e.g., Glycopyrrolate, Oxybutynin) Cost in Korea

Oral anticholinergic medications such as Glycopyrrolate and Oxybutynin are used in Korea for managing conditions like excessive sweating (primary hyperhidrosis) and as adjuncts in Hidradenitis Suppurativa treatment. These medications reduce sweat gland activity systemically. While not always a first-line therapy, they are commonly prescribed by dermatologists or internal medicine specialists when topical agents fail. Their cost in Korea remains relatively affordable, especially under specialist care.

πŸ“Š Comprehensive Cost Overview

Medication Estimated Monthly Cost (KRW) Description
Glycopyrrolate 1–2mg Tablets 40,000 – 90,000 Used to reduce generalized sweating; requires prescription
Oxybutynin 5mg Tablets 30,000 – 70,000 Effective for palmoplantar and axillary hyperhidrosis

πŸ” Detailed Cost Analysis by Component

Component Cost (KRW) Details
Initial Dermatologist/Physician Consultation 20,000 – 35,000 Diagnosis, suitability assessment, and prescription
1-Month Supply of Glycopyrrolate 40,000 – 90,000 May vary based on brand and dosage
1-Month Supply of Oxybutynin 30,000 – 70,000 Often available at community or hospital pharmacies

βž• Additional & Optional Services Cost

Service Cost (KRW) Details
Blood Pressure & Side Effect Monitoring 10,000 – 25,000 Regular follow-up to assess side effects like dry mouth or dizziness
Combination Therapy with Topical Antiperspirants 30,000 – 100,000 Often recommended for synergistic effect

πŸ₯ Clinical Treatment Costs

Facility Type Total Monthly Cost (KRW) Includes
General Hospitals 80,000 – 150,000 Consultation, prescription, 1-month medication
Dermatology Clinics 60,000 – 130,000 Initial consult + follow-up + monthly supply
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025
New paragraph
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025
By Mijan Mijan August 8, 2025